James Crowe Jr. Archives
Nine faculty honored with endowed chairs
Jan. 24, 2014—Nine Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration Jan. 22 at the Student Life Center.
Vaccine researchers ready as new flu strain evolves
Aug. 22, 2013—A worrisome new avian influenza virus, called H7N9, emerged this spring in Eastern China.
VU researchers ‘goldsmith’ new RSV vaccine approach
Jul. 18, 2013—Vanderbilt vaccine researchers are using gold nanotechnology to develop a new approach to making vaccines.
Structural snapshot hints at new influenza approach
Feb. 21, 2013—A careful look at how the body’s natural defenses disarm virulent strains of influenza hints at the possibility of a way to fight the flu.
Targeting post-transplant diabetes
Apr. 12, 2012—Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.
On the tail of RSV infection mechanism
Feb. 15, 2012—New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.
Diversity key in antibody repertoire
Oct. 7, 2011—Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines.
Aliquots – VUMC research highlights
Jan. 6, 2011—RSV prefers stressed cells “Stress granules” – globs of proteins and RNAs – form inside cells in response to environmental stressors and are thought to regulate protein production. Several viruses induce stress granule formation, but the function of these structures during virus replication is not well understood. James Crowe Jr., M.D., and colleagues report that...
